VWWMG
IBB icon

Vermillion & White Wealth Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150
Closed -$21.7K – 601
2025
Q3 		$21.7K Buy
+150
New +$20.5K 0.01% 251

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vermillion & White Wealth Management Group's IBB Position: Q4 2025 in Review

Vermillion & White Wealth Management Group sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 150 shares — an estimated $21.7K sold.

Vermillion & White Wealth Management Group first reported a position in IBB in Q3 2025 and held it in 1 quarter. The position peaked at $21.7K in Q3 2025. 959 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Vermillion & White Wealth Management Group reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 150 iShares Biotechnology ETF shares in Q4 2025, an estimated $21.7K.
  • Vermillion & White Wealth Management Group first reported a position in iShares Biotechnology ETF in Q3 2025 and held it in 1 quarter.
  • Vermillion & White Wealth Management Group's iShares Biotechnology ETF position peaked at $21.7K in Q3 2025.
  • 959 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2025, filed 18 Feb 2026.